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The manuscript describes the establishment of the 19F NMR 5 
signal regulation and the application of this strategy to develop 
the multi-modal 19F NMR probe for monitoring enzymatic 
activity using nanoparticles as a signal regulator. Water-soluble 
perfluorinated cubic silsesquioxane was synthesized and 
immobilized onto the silica nanoparticles for suppressing the 10 
signals. 19F NMR signals of the probes were recovered by 
releasing from nanoparticles. 
 Magnetic resonance imaging (MRI) is one of the powerful 
diagnostic tools as a noninvasive diagnosis method, and 
through the use of the contrast agents, site- and time-selective 15 
information can be received. 19F MRI using fluorinated 
compounds as the contrast agents has recently gathered 
attentions because less existence of endogenous fluorine atom 
gives the high signal to noise ratio in the images.1 In addition, 
several groups have reported functional 19F NMR probes 20 
which can detect the enzymatic activity or the environmental 
alteration by changing of their signal heights or chemical 
shifts.2 Furthermore, fusion of multiple information has been 
increasingly required for improving the diagnosis accuracy, 
thus molecular imaging probes for next generation should 25 
equip the multimodality.3 
 The accumulation of an equal fluorine group is essential for 
improving the sensitivity of the 19F NMR signals, however, 
perfluorinated compounds would exhibit extremely poor 
water-solubility. One way to solve these problems is to use 30 
cubic octameric polyhedral oligomeric silsesquioxanes 
(POSS) as a scaffold for the accumulation of fluorine atoms. 
POSS are highly-water-soluble nanoblocks, and it has been 
reported that POSS could form the compact structure 
compared to the same generation of poly(amido)amine 35 
dendrimers.4 These characteristics can be beneficial for the 
accumulation of the probe molecules with high density to 
improve sensitivity. 
 Herein, we report the regulation system of 19F NMR signals 
for monitoring bioreactions based on the water-soluble 40 
perfluorinated POSS-coated silica nanoparticles (NPs). The 
enzymatic reaction can be monitored by the enhancement of 
19F NMR signals. In addition, we develop the multi-modal 
probe with dual detection of fluorescence and 19F NMR. This 
is the first example that the NPs can be used for the NMR 45 
signal regulation. 
 The chemical structures and synthesis of the water-soluble 
perfluorinated POSS (F-POSS) using octaammonium POSS 15 
as a starting material are shown in Scheme 1. F-POSS has 
trifluoroacetyl groups as the 19F NMR signal moiety. The 50 
major product was identified with modified POSS containing 
POSS-TFA4 from MALDI-TOF-MS measurements. The 
solubility of F-POSS in PBS (pH = 7.5) at 25 °C was at least 
10 mM (120 mM F atom concentration), and the significant 
peak broadening following the decrease of sensitivity was not 55 
observed by adding to BSA (1 mg/mL) or the pH altering 
between pH 5 to 9. In addition, the degradation of F-POSS 
was not observed after 24 h incubation at 37 °C at pH 7.0 in 
the presence of proteinase K. The detection limit was 
determined to be 10 PM using 19F NMR spectrometer with a 60 
20 mm surface coil at 9.4 T. These results suggest that F-
POSS could provide clear 19F NMR signals without loss of 





































































































aReagents: (a) ethyl trifluoroacetate, triethylamine, methanol, 83%; (b) 
phosphorus oxytrichloride, triethylamine, chloroform; (c) amino-modified 
silica nanoparticles, chloroform. 
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 Scheme 2 illustrates the strategy for the regulation of 19F 
NMR signals. In a solid state, the sensitivity of NMR signal 
was decreased by the acceleration of transverse relaxation 
time and the anisotropy of the spin toward the external 
magnetic fields. On silica NPs, the molecular rotation of the 5 
perfluorinated POSS should be highly restricted, and the 
NMR signals from the probe can be decreased.2b After 
releasing the probe triggered by an enzymatic reaction, the 
NMR signals are recovered. Therefore, the enzyme activity 
can be detected by the enhancement of the signal intensity of 10 
19F NMR. 
 NPs in the range of 20 nm to 400 nm in diameter show 
tumor-selective integration known as the enhanced 
permeability and retention (EPR) effect.6 In addition, the 
silica NPs can be attached with the fluorophores, and these 15 
fluorescent NPs displayed good feasibility for in vivo imaging 
because of photo-stability and less toxicity.7 We prepared 
amino-coated silica NPs averaging 150 nm and 280 nm in 
diameter containing or non-containing the fluorophores with 
the Stöber method.8 Amino groups on F-POSS were 20 
covalently linked to the amino groups on the silica NPs via 
the phosphordiamidate linker which can be cleaved by the 
enzymatic digestion of alkaline phosphatase (AP).9 A class of 
AP is generally existing in the cell cytoplasm or surface in the  
whole body, and they can digest phosphodiester analog 25 
without specificity.9 Thus, in combination with the EPR effect, 
the monitoring system of the AP activity could be a new 
method for the early cancer diagnosis. 
 The reaction mixture containing F-POSS and triethylamine 
in chloroform was added to phosphorus oxytrichloride at room 30 
temperature, and subsequently the amino-coated silica NPs 
were suspended in the mixture in one pot. The reaction was 
monitored by ninhydrin reagents for checking the 
consumption of the amino groups on the NPs. After 
purification with centrifuges and drying, we confirmed from 35 
dynamic light scattering that unexpected aggregation of the 
modified NPs was not formed after modification with F-POSS, 
and the diameters of synthetic NPs were determined from the 
TEM images.10 From the fitting to the standard curve on 19F 
NMR signal intensity, it was estimated that 100 (± 20) nmol / 40 
mg of F-POSS was immobilized onto the silica NPs. 
Undesired decomposition of the probe less occurred by the 
proteinase K treatment or the pH alteration between pH 5 to 9. 
 The reactivity of the F-POSS-coated silica NPs with AP 
was investigated. Initially, the modified NPs averaging 150 45 
nm in diameter were used. The reaction mixtures containing 3 
mg / mL of the modified NPs (300 PM F-POSS) and AP in 50 
mM sodium phosphate and 100 mM Tris–HCl buffer (pH = 
7.0) were incubated at 37 °C, and 19F NMR signals of the 
mixture were monitored (Figure 1). The signal was linearly 50 
increasing and stopped after 12 h incubation (t50 = 6.2 h). In 
the absence of the enzyme, NMR signal was hardly detected 
even after 24 h incubation. In the case of 280 nm diameter of 
the NPs, the rate of the signal intensity was similar extent as 
those of 150 nm (t50 = 6.0 h).11 These results indicate that the 55 
19F NMR signals could be obtained independently on the size 
of NPs. The time-scale of these reactions might be adequate to 
obtain the EPR effect due to the prevention from non-specific 
digestion of the NPs during the transportation. 
 We demonstrated the multimodal detection with 60 
fluorescence and 19F NMR for the enzymatic activity. Time 
course of 19F NMR signals of the F-POSS-modified silica NPs 
containing fluorescein-5(6)-carboxylic acid is shown in Figure 
2a.12 AP activity induced a signal enhancement after 3 h 
incubation, and the signal intensity was saturated after 12 h 65 
incubation. This result corresponds with the data shown in 
Figure 1. Fluorescence emission from fluorescent silica NPs 
was constantly observed during reactions without 
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Fig. 1 Time-course of the enzymatic reaction. F-POSS-coated silica NPs 
(1.5 mg) were incubated in 500 PL of the reaction solutions containing 
AP (5 U) (square dots) and non-containing AP (circular dots) in 50 mM 
sodium phosphate, 25 mM Tris–HCl, and 0.05 mM EDTA (pH = 7.0) at 
37 °C. The reaction yields were monitored with 19F NMR and calculated 




Fig. 2 (a) 19F NMR spectra of F-POSS-coated silica NPs in diameter of 
150 nm containing fluorescein-5(6)-carboxylic acid in enzymatic 
hydrolysis with AP. (b) The fluorescence image was taken using a 
transilluminator (365 nm) through a 480-nm long pass emission filter. 
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photobleaching (Figure 2b). These data suggest that the 
fluorescence can be used as a reference to zero for scanning 
the distribution of the probes and estimating the absolute 
intensity of 19F NMR signal.13 Although the sensitivity of the 
probe for acquiring clear signals in the 19F NMR spectra was 5 
lower than that for the fluorescence image, our system could 
have a possibility to improve sensitivity by employing POSS-
core dendrimers for incorporating the larger number of 
fluorine atoms into the probe. 
 In conclusion, we describe here a novel 19F NMR probes 10 
using perfluorinated POSS, and the enzymatic activity can be 
monitored by the enhancement of their 19F NMR signals. 
Using the fluorescent NPs, the dual detection with 19F NMR 
and fluorescence was accomplished potentially for the 
simultaneous monitoring of the enzymatic activity and the 15 
biodistribution. Though there reminds room to optimize 
reactivity or to evaluate the toxicity and the biodistiribution in 
living animals, our system could be applied to the sensing of 
not only pH via hydrolysis but also other kinds of enzymes 
such as nucleases and proteases by the modification with the 20 
linker. In addition, a detection modality can be added by the 
modulation of the material of NPs. It is expected that this 
strategy is helpful for designing new generation of molecular 
imaging probes. 
 This study was conducted as a part of the project, ''R&D of 25 
Molecular Imaging Equipment for Malignant Tumor Therapy 
Support,'' supported by NEDO (New Energy and Industrial 
Technology Development Organization). We thank Prof. Y. 
Tsuji and Dr. T. Fujiwara for the measurement of 19F NMR. 
We thank Prof. M. Nagao and Ms. M. Chujo for the MTT 30 
assay. We thank Prof. I. Hamachi and Mr. S. Fujishima for 
taking the fluorescence images.  
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